| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/24/2006 | EP1553942B1 Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent |
| 05/24/2006 | EP1474425B1 Deazapurines and uses thereof |
| 05/24/2006 | EP1465577A4 Methods for improving the aesthetic appearance of skin |
| 05/24/2006 | EP1427428B1 Apoptosis-mimicking natural vesicles and use thereof in medical treatment |
| 05/24/2006 | EP1389619B1 Pkb-3564 substance with neovascularization inhibitory activity |
| 05/24/2006 | EP1384477B1 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases |
| 05/24/2006 | EP1383480A4 Lipid-comprising drug delivery complexes and methods for their production |
| 05/24/2006 | EP1370526B1 Diamides which inhibit tryptase and factor xa activity |
| 05/24/2006 | EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/24/2006 | EP1325002B1 1,2,5,10-tetrahydropyridazino¬4,5-b|quinoline-1,10-diones and their use for the treatment of pain |
| 05/24/2006 | EP1322383B1 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 05/24/2006 | EP1259520B1 Novel purines |
| 05/24/2006 | EP1226129B1 Methods and compositions utilizing quinazolinones |
| 05/24/2006 | EP1100492B1 INDOLE sPLA2 INHIBITORS |
| 05/24/2006 | EP1015585B1 Tie ligand homologues |
| 05/24/2006 | EP1001974B1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2006 | EP0858337B1 A pharmaceutical composition for the treatment of autoimmune diseases |
| 05/24/2006 | EP0719295B1 Polymeric matrices and their uses in pharmaceutical compositions |
| 05/24/2006 | DE19543271B4 Orales pharmazeutisches Präparat An oral pharmaceutical composition |
| 05/24/2006 | DE102004044884A1 Substituierte bizyklische Imidazo-3-yl-amin-Verbindungen Substituted bicyclic imidazo-3-yl-amine compounds |
| 05/24/2006 | DE10128266B4 Verfahren zur Herstellung eines Extrakts aus Zingiber officinale A process for preparing an extract of Zingiber officinale |
| 05/24/2006 | CN1777597A Indazole having analgesic activity |
| 05/24/2006 | CN1777595A Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 05/24/2006 | CN1777425A Muscarinic M1 receptor agonists for pain management |
| 05/24/2006 | CN1775801A Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 05/24/2006 | CN1775270A Yuying preparation and new preparing method |
| 05/24/2006 | CN1775267A Kaikoujian extract, Its preparing method and use |
| 05/24/2006 | CN1775256A Capsule for treating rheumatalgia |
| 05/24/2006 | CN1775230A Enhanced Xihuang formulation and new preparing method |
| 05/24/2006 | CN1775229A Chinese medicine dropping pill for promoting blood circulation, removing blood stasis, alleviating pain and detumescence and its preparing method |
| 05/24/2006 | CN1775211A Method and composition for reducing to xicity related to leflunomide treatment |
| 05/24/2006 | CN1257169C Bicyclic imidazo-3-yl-amine derivatives |
| 05/24/2006 | CN1257160C Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 05/24/2006 | CN1256979C Traditional Chinese medicinal prepn. capsule for treating presistent febris during common cold |
| 05/24/2006 | CN1256954C Argyi leaf oil dripping pills and its preparation process |
| 05/24/2006 | CN1256945C Suppository for treating cancer pain and its preparation method |
| 05/24/2006 | CN1256942C Application of dihydromyricetrin |
| 05/23/2006 | US7049455 Process for producing shogaols and intermediates for the synthesis thereof |
| 05/23/2006 | US7049439 Immunomodulators for inducing cytokine biosynthesis; viricides; antitumor agents |
| 05/23/2006 | US7049422 Tumor necrosis related receptor, TR7 |
| 05/23/2006 | US7049412 Genetic engineered nucleic acids codes these enzymes; therapy for bone disorders; monoclonal antibodies |
| 05/23/2006 | US7049407 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer |
| 05/23/2006 | US7049329 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists |
| 05/23/2006 | US7049327 For therapy of pain |
| 05/23/2006 | US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/23/2006 | US7049325 Quinoline derivatives as anti-inflammatory agents |
| 05/23/2006 | US7049322 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 05/23/2006 | US7049321 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 05/23/2006 | US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis |
| 05/23/2006 | US7049318 1-Benzyl-2-(5-benzylamino-1-methyl-6-oxo-4-pyridin-4-yl-1,6-dihydro-pyrimidin-2-ylamino)-ethyl]-(S)-carbamic acid tert-butyl ester or derivatives |
| 05/23/2006 | US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity |
| 05/23/2006 | US7049308 For therapy of inflammatory or painful disorder |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | US7049119 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/23/2006 | US7048946 Formulation for controlled release of drugs by combining hyrophilic and hydrophobic agents |
| 05/23/2006 | US7048932 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 05/23/2006 | US7048909 Aerosols containing nondegraded atenolol, pindolol, esmolol, propranolol, or metoprolol |
| 05/23/2006 | US7048906 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 05/23/2006 | CA2339630C Carboline derivatives as cgmp phosphodiesterase inhibitors |
| 05/23/2006 | CA2263921C Oral delayed immediate release formulation and method of preparation therefor |
| 05/18/2006 | WO2006053166A1 8h-imidazo[4,5-d]thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 05/18/2006 | WO2006053121A2 Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity |
| 05/18/2006 | WO2006053120A1 IMIDAZO-FUSED THIAZOLO[4,5-b]PYRIDINE BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME |
| 05/18/2006 | WO2006052026A1 Acid salt of benzimidazole derivative and crystal thereof |
| 05/18/2006 | WO2006051997A1 Cystein dioxygenase inducer |
| 05/18/2006 | WO2006051826A1 Nitrogenous heterocyclic compound and pharmaceutical use thereof |
| 05/18/2006 | WO2006051819A1 Drug for external use and adhesive patch |
| 05/18/2006 | WO2006051818A1 Drug for external use and adhesive patch |
| 05/18/2006 | WO2006051704A1 Imine compound |
| 05/18/2006 | WO2006051340A1 Novel form of celecoxib |
| 05/18/2006 | WO2006050998A1 5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics |
| 05/18/2006 | WO2006050965A1 Pyrimidine compounds as histamine modulators |
| 05/18/2006 | WO2006032436A3 Use of microproteins as tryptase inhibitors |
| 05/18/2006 | WO2006020979A3 Factor vii conjugates for selectively treating neovascularization disorders |
| 05/18/2006 | US20060106220 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 05/18/2006 | US20060106206 plant extracts is produced from solvent extraction, contains a triglucose-picene structure compounds; as antiinflammatory agents treating autoimmune disease, cosmetic composition for prevent aging, and other skin disorders |
| 05/18/2006 | US20060106102 Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif) |
| 05/18/2006 | US20060106082 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation |
| 05/18/2006 | US20060106075 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 05/18/2006 | US20060106066 Benzyl substituted (piperidin-4-yl)aminobenzamido derivatives |
| 05/18/2006 | US20060106059 Melanocortin receptor ligands |
| 05/18/2006 | US20060106050 Thrombin receptor antagonists |
| 05/18/2006 | US20060106048 Furoisoquinoline derivative and use thereof |
| 05/18/2006 | US20060105987 Sulfur-containing phospholipid derivatives |
| 05/18/2006 | US20060105423 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 05/18/2006 | US20060105048 Remedy |
| 05/18/2006 | US20060104998 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent |
| 05/18/2006 | US20060104974 CD147 binding molecules as therapeutics |
| 05/18/2006 | DE102004055633A1 New 5-substituted quinoline and isoquinoline derivatives are glucocorticoid receptor binders useful for treating inflammatory diseases e.g. alveolitis, Sjogren's syndrome, atopic dermatitis, acute lymphatic leukemia, rhinitis and emesis |
| 05/18/2006 | CA2587667A1 Imine compound |
| 05/18/2006 | CA2587192A1 Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity |
| 05/18/2006 | CA2586316A1 Pyrimidine compounds as histamine modulators |
| 05/18/2006 | CA2574326A1 Novel form of celecoxib |
| 05/17/2006 | EP1657255A1 Novel protein and method for producing the protein |
| 05/17/2006 | EP1657247A1 Steroidal compounds for inhibiting steroid sulphotase |
| 05/17/2006 | EP1657233A1 Lipoxin compounds |
| 05/17/2006 | EP1656952A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 05/17/2006 | EP1656936A1 Macrophage activation inhibitor |
| 05/17/2006 | EP1656376A1 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases |
| 05/17/2006 | EP1656368A2 Substituted hertocyclic derivatives useful as antidiabetic and antiobesity agents and method |